Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insights

Set Alert for Digital Health

Minute Insight: Abbott Sponsors New Physician Training Program To Diversity Clinical Trial Leadership

The company is partnering with the non-profit organization Women as One and the Global Cardiovascular Clinical Trialists to help train physicians from underrepresented populations to lead clinical trials.

Minute Insights Diversity & Inclusion

Minute Insight: FDA Clears Fujirebio’s IVD For Alzheimer’s Disease

Fujirebio Diagnostics’ Lumipulse G beta-amyloid ratio test assesses beta-Amyloid pathology in patients with suspected Alzheimer’s disease or other causes of cognitive decline. Lab tests for Alzheimer’s are already available, but this the first in vitro diagnostic for the disease that the agency has authorized.

Minute Insights In Vitro Diagnostics

Minute Insight: Strados Earns FDA 510(k) To Let Patients Use RESP Sensor At Home

The FDA cleared Strados’ RESP sensor to be incorporated into at-home remote monitoring of patients with pulmonary disease in addition to in-hospital monitoring. Strados expects the in-home indication will help physicians better understand their patients’ respiratory health “journey.”

Minute Insights Respiratory

Minute Insight: Guardant Launches Shield Test To Detect Colorectal Cancer In Average-Risk Adults

The Shield lab-developed test was validated in a 309-patient study, demonstrating 91% sensitivity for colorectal cancer. The company is sponsoring the ECLIPSE study to support a PMA for the test.

Minute Insights In Vitro Diagnostics

Minute Insight: Biofourmis Raises $300M To Fund Digital Drug-Companion Therapies

The Boston company will use the new investment to continue scaling its virtual care business. Biofourmis also announced that medtech veteran Omar Ishrak is joining the company’s board as its chairman.

Minute Insights Patient Monitoring

Minute Insight: Phage-Based TB Diagnostic Demonstrates Capability

Actiphage, developed by PBD Biotech could be a key tool in the fight against tuberculosis.

Minute Insights Clinical Trials

Minute Insight: NHS Employs OCTAPUS AI To Predict Lung Cancer Recurrence

The OCTAPUS AI study demonstrated that machine learning was a better tool than typical assessments used to predict recurrence of non-small cell lung cancer.

Minute Insights Artificial Intelligence

Minute Insight: What Is Going On With Butterfly Network’s Leadership?

Since going public, the company’s share price has flopped, its board has seen a flurry of appointments and resignations over the past year, and now the company is facing investor lawsuits.

Minute Insights Legal Issues
See All
UsernamePublicRestriction

Register